Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-03-2024 | Abatacept | Case report

Abatacept/ciclosporin/cyclophosphamide

Lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Jaiswal SR, et al. Abatacept and Ptcy Based Gvhd Prophylaxis with CNI/Sirolimus for Haploidentical HCT: Donor KLRC2 Genotype Impacts Outcome. Blood 142 (Suppl. 1): 4928, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-188981 [abstract] Jaiswal SR, et al. Abatacept and Ptcy Based Gvhd Prophylaxis with CNI/Sirolimus for Haploidentical HCT: Donor KLRC2 Genotype Impacts Outcome. Blood 142 (Suppl. 1): 4928, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-188981 [abstract]
Metadata
Title
Abatacept/ciclosporin/cyclophosphamide
Lack of efficacy
Publication date
01-03-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-53858-9

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Epinephrine

Case report

Multiple drugs

Case report

Blinatumomab